James Knutson
Kirkland, WANPI 1568584571
Payments from drug & device makers
$10,930,434in general payments, 2019–2025
Across 1,170 payments — averaging $9342.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3.1M
- Otsuka Pharmaceutical Development & Commercialization, Inc.$2.7M
- Boehringer Ingelheim$1.1M
- F. Hoffmann-la Roche AG$841K
- Supernus Pharmaceuticals, Inc.$548K
- Acadia Pharmaceuticals Inc$472K
- plus $2.1M from 25 others
$45,202in research payments, 2019–2025
Across 26 payments — averaging $1738.54 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Axsome Therapeutics, Inc.$33K
- Purdue Pharma L.p.$8K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$2K
- Acadia Pharmaceuticals Inc$1K
- Eli Lilly$878
General payments by program year
19
21
22
23
24
25
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.